2026 Q2 Portfolio Activity
In 2026 Q2, Squadron Capital Management LLC maintained a portfolio of 62 distinct positions. The most significant new addition was ENLIVEN THERAPEUTICS INC, now representing 2.52% of the total fund value. They heavily accumulated shares in C4 THERAPEUTICS INC, increasing the position by 220.0%. Conversely, Squadron Capital Management LLC completely exited their position in KALVISTA PHARMACEUTICALS INC.
Position History
hover any row below to update
Loading…
Total Positions
62
Quarter
2026 Q2
Top Holding
RLMD (15.8%)
Top 10 Concentration
66.2%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 62
Squadron Capital Management LLC Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
RLMD
RELMADA THERAPE...
|
Healthcare | 15.78% | 21.61% |
#1
Prev: #1
|
6.5 |
—
|
-1,124,571 | -13.3% |
P
S
|
7,350,000 | $50,862,000 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CCCC
C4 THERAPEUTICS...
|
Healthcare | 10.43% | 2.17% |
#2
12
Prev: #14
|
8.5 |
—
|
4,950,000 | 220.0% |
P
S
|
7,200,000 | $33,624,000 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
COGT
COGENT BIOSCIEN...
|
Healthcare | 10.39% | 11.11% |
#3
1
Prev: #2
|
7.0 |
—
|
77,508 | 9.8% |
P
S
|
865,000 | $33,475,500 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
KOD
KODIAK SCIENCES...
|
Healthcare | 6.05% | 5.31% |
#4
Prev: #4
|
5.4 |
—
|
120,000 | 31.6% |
P
S
|
500,000 | $19,480,000 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RLAY
RELAY THERAPEUT...
|
Healthcare | 5.63% | 2.45% |
#5
7
Prev: #12
|
5.3 |
—
|
297,500 | 44.2% |
P
S
|
970,000 | $18,148,700 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ZNTL
ZENTALIS PHARMA...
|
Healthcare | 5.57% | 3.11% |
#6
3
Prev: #9
|
2.7 |
—
|
69,000 | 1.9% |
P
S
|
3,700,000 | $17,945,000 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
EWTX
EDGEWISE THERAP...
|
Healthcare | 3.66% | 4.04% |
#7
1
Prev: #6
|
2.0 |
—
|
-60,000 | -17.1% |
P
S
|
290,000 | $11,782,700 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MAZE
MAZE THERAPEUTI...
|
Healthcare | 3.10% | 2.82% |
#8
2
Prev: #10
|
3.7 |
—
|
77,500 | 30.1% |
P
S
|
335,000 | $9,996,400 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IVA
INVENTIVA SA
|
Healthcare | 2.86% | 1.09% |
#9
15
Prev: #24
|
4.1 |
—
|
1,900,000 | 355.1% |
P
S
|
2,435,000 | $9,204,300 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ANL
ADLAI NORTYE LT...
|
Healthcare | 2.73% | 3.21% |
#10
2
Prev: #8
|
1.1 |
—
|
-500,355 | -39.5% |
P
S
|
764,876 | $8,796,074 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ELVN
ENLIVEN THERAPE...
|
Healthcare | 2.52% | — |
#11
Prev: #—
|
4.5 |
—
|
160,000 | — |
NEW
|
160,000 | $8,120,000 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
AVBP
CALL
ARRIVENT BIOPHA...
|
CALL Option | 1.97% | — |
#12
Prev: #—
|
4.3 |
—
|
183,000 | — |
NEW
|
183,000 | $6,357,420 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PALI
PALISADE BIO IN...
|
Healthcare | 1.95% | 1.92% |
#13
3
Prev: #16
|
1.8 |
—
|
no change | no change |
P
S
|
3,000,000 | $6,270,000 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BIOA
CALL
BIOAGE LABS INC
|
CALL Option | 1.90% | — |
#14
Prev: #—
|
4.3 |
—
|
250,000 | — |
NEW
|
250,000 | $6,127,500 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IKT
INHIBIKASE THER...
|
Healthcare | 1.89% | 2.15% |
#15
Prev: #15
|
1.3 |
—
|
-500,000 | -14.3% |
P
S
|
3,000,000 | $6,090,000 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ADAG
ADAGENE INC
|
Healthcare | 1.63% | — |
#16
Prev: #—
|
4.2 |
—
|
1,250,000 | — |
NEW
|
1,250,000 | $5,250,000 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
FBRX
FORTE BIOSCIENC...
|
Healthcare | 1.48% | — |
#17
Prev: #—
|
4.1 |
—
|
225,000 | — |
NEW
|
225,000 | $4,781,250 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RZLT
CALL
REZOLUTE INC
|
CALL Option | 1.45% | — |
#18
Prev: #—
|
4.1 |
—
|
900,000 | — |
NEW
|
900,000 | $4,680,000 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IFRX
INFLARX NV
|
Healthcare | 1.39% | — |
#19
Prev: #—
|
4.1 |
—
|
2,000,000 | — |
NEW
|
2,000,000 | $4,480,000 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ASMB
ASSEMBLY BIOSCI...
|
Healthcare | 1.36% | — |
#20
Prev: #—
|
4.0 |
—
|
160,000 | — |
NEW
|
160,000 | $4,396,800 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CMPS
CALL
COMPASS PATHWAY...
|
CALL Option | 1.34% | — |
#21
Prev: #—
|
4.0 |
—
|
305,000 | — |
NEW
|
305,000 | $4,315,750 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PMN
PROMIS NEUROSCI...
|
Healthcare | 1.33% | 1.51% |
#22
2
Prev: #20
|
1.5 |
—
|
no change | no change |
P
S
|
324,977 | $4,276,697 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CTNM
CONTINEUM THERA...
|
Healthcare | 1.32% | — |
#23
Prev: #—
|
4.0 |
—
|
260,000 | — |
NEW
|
260,000 | $4,261,400 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CMPS
COMPASS PATHWAY...
|
Healthcare | 1.32% | — |
#24
Prev: #—
|
4.0 |
—
|
300,000 | — |
NEW
|
300,000 | $4,245,000 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
DFTX
DEFINIUM THERAP...
|
Healthcare | 1.24% | — |
#25
Prev: #—
|
4.0 |
—
|
85,000 | — |
NEW
|
85,000 | $3,998,400 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SLGL
SOL-GEL TECHNOL...
|
Healthcare | 1.20% | 0.90% |
#26
3
Prev: #29
|
3.5 |
—
|
21,000 | 67.7% |
P
S
|
52,000 | $3,855,280 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BIOA
BIOAGE LABS INC
|
Healthcare | 1.18% | — |
#27
Prev: #—
|
4.0 |
—
|
155,000 | — |
NEW
|
155,000 | $3,799,050 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SCYX
SCYNEXIS INC
|
Healthcare | 0.96% | 2.56% |
#28
17
Prev: #11
|
0.4 |
—
|
-6,851,811 | -90.1% |
P
S
|
756,884 | $3,080,518 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
PRQR
PROQR THRAPEUTI...
|
Healthcare | 0.87% | — |
#29
Prev: #—
|
3.8 |
—
|
1,511,496 | — |
NEW
|
1,511,496 | $2,811,383 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
IRON
CALL
DISC MEDICINE I...
|
CALL Option | 0.68% | — |
#30
Prev: #—
|
3.8 |
—
|
30,000 | — |
NEW
|
30,000 | $2,194,200 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RZLT
REZOLUTE INC
|
Healthcare | 0.65% | — |
#31
Prev: #—
|
3.8 |
—
|
403,410 | — |
NEW
|
403,410 | $2,097,732 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
LPCN
LIPOCINE INC NE...
|
Healthcare | 0.64% | 1.32% |
#32
10
Prev: #22
|
3.3 |
—
|
360,000 | 80.0% |
P
S
|
810,000 | $2,073,600 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ZNTL
CALL
ZENTALIS PHARMA...
|
CALL Option | 0.64% | — |
#33
Prev: #—
|
3.8 |
—
|
426,000 | — |
NEW
|
426,000 | $2,066,100 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CCCC
CALL
C4 THERAPEUTICS...
|
CALL Option | 0.58% | — |
#34
Prev: #—
|
3.7 |
—
|
400,000 | — |
NEW
|
400,000 | $1,868,000 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RARE
CALL
ULTRAGENYX PHAR...
|
CALL Option | 0.57% | — |
#35
Prev: #—
|
3.7 |
—
|
55,000 | — |
NEW
|
55,000 | $1,836,450 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CUE
CUE BIOPHARMA I...
|
Healthcare | 0.49% | — |
#36
Prev: #—
|
3.7 |
—
|
50,000 | — |
NEW
|
50,000 | $1,578,000 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CALC
CALCIMEDICA INC
|
Healthcare | 0.40% | — |
#37
Prev: #—
|
3.7 |
—
|
1,244,864 | — |
NEW
|
1,244,864 | $1,282,210 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
QUINCE THERAPEU...
|
|
Unknown | 0.23% | — |
#38
Prev: #—
|
3.6 |
—
|
40,375 | — |
NEW
|
40,375 | $734,421 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
NVCT
CALL
NUVECTIS PHARMA...
|
CALL Option | 0.22% | — |
#39
Prev: #—
|
3.6 |
—
|
38,700 | — |
NEW
|
38,700 | $711,693 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
KTTA
PASITHEA THERAP...
|
Healthcare | 0.16% | 0.57% |
#40
10
Prev: #30
|
0.1 |
—
|
-1,100,000 | -52.4% |
P
S
|
1,000,000 | $515,400 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
INM
INMED PHARMACEU...
|
Healthcare | 0.16% | — |
#41
Prev: #—
|
3.6 |
—
|
325,000 | — |
NEW
|
325,000 | $503,750 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NMRA
NEUMORA THERAPE...
|
Healthcare | 0.05% | — |
#42
Prev: #—
|
3.5 |
—
|
100,000 | — |
NEW
|
100,000 | $170,000 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NXTC
NEXTCURE INC
|
Healthcare | 0.03% | 1.04% |
#43
16
Prev: #27
|
0.0 |
—
|
-200,536 | -75.7% |
P
S
|
64,464 | $103,142 | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NEUP
NEUPHORIA THERA...
|
Healthcare | 0.00% | 0.11% |
Sold All 😨
(Was: #37) |
0.0 |
—
|
-76,728 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
HOWL
WEREWOLF THERAP...
|
Healthcare | 0.00% | 0.17% |
Sold All 😨
(Was: #36) |
0.0 |
—
|
-563,535 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
SPRB
SPRUCE BIOSCIEN...
|
Healthcare | 0.00% | 0.29% |
Sold All 😨
(Was: #35) |
0.0 |
—
|
-12,200 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TXMD
THERAPEUTICSMD ...
|
Healthcare | 0.00% | 0.31% |
Sold All 😨
(Was: #34) |
0.0 |
—
|
-420,421 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ZNTL
CALL
ZENTALIS PHARMA...
|
Healthcare | 0.00% | 0.34% |
Sold All 😨
(Was: #33) |
0.0 |
—
|
-400,000 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TRAW
TRAWS PHARMA IN...
|
Healthcare | 0.00% | 0.34% |
Sold All 😨
(Was: #32) |
0.0 |
—
|
-511,714 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RLAY
CALL
RELAY THERAPEUT...
|
Healthcare | 0.00% | 0.55% |
Sold All 😨
(Was: #31) |
0.0 |
—
|
-150,000 | -100.0% |
CLOSED
|
— | $— | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 |
Showing 1-50 of 62 holdings